-
NeOnc Technologies establishes $75 million at-the-market equity program
-
NeOnc Technologies Holdings (NTHI) Misses Q4 EPS by 320c
-
NeOnc Technologies Holdings (NTHI) files $300M mixed shelf
-
Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holdings, Inc. (NTHI)
-
New to The Street to Broadcast Executive Leadership Interviews Tonight at 6:30 PM EST on Bloomberg Television Across the U.S., MENA and Latin America
-
New to The Street to Broadcast Show #726 on Bloomberg at 6:30 PM EST Featuring Vivos Therapeutics (NASDAQ:VVOS), Aeries Technology (NASDAQ:AERT), Virtuix Holdings (NASDAQ:VTIX), and Stardust Power (NA
-
New to The Street(R) Airs Tonight on Bloomberg Television Across the U.S., MENA & Latin America
-
NeOnc Technologies Holdings (NTHI) files for 2.95M share offering by selling stockholders
-
New to The Street Broadcasts Today on Bloomberg Across the U.S., MENA, and Latin America
-
NeOnc Technologies secures $16 million PIPE investment led by Cinctive
-
Stonegate Capital Partners Initiates Coverage on NeOnc Technologies Holdings, Inc. (NTHI)
-
New to The Street Airs Tonight on Bloomberg Television - Show No. 712 Sponsored Programming Spotlighting Public and Private Market Innovators
-
New to The Street Show #710 Airs Tonight at 6:30 PM EST on Bloomberg Television
-
NeOnc Technologies reports ultrasound boosts NEO100 brain tumor treatment
-
NeOnc Technologies Holdings (NTHI) Misses Q3 EPS by 45c
-
Meet the Companies - New to The Street's Accredited Investor Event Returns October 21-22 at Hudson Yards, NYC
-
New to The Street to Broadcast Tonight on Fox Business 10:30 PM PST Featuring NeOnc Technologies, FLOKI, XION, Sharps Technology, and Aeries Technology
-
New to The Street to Broadcast Saturday, September 27th Featuring NeOnc Pharma $NTHI and Other Innovative Companies
-
New to The Street to Broadcast Episode 686 Tonight on Bloomberg Television at 6:30 PM EST
-
NeOnc Technologies gets FDA nod for brain cancer drug Phase II trial
-
NeOnc Technologies secures $50 million investment from Quazar Investment
-
New to The Street's Esteemed Client NeOnc Technologies Finalizes $50 Million Strategic Partnership with Quazar Investment as NuroMENA Holdings Receives ADGM Incorporation
-
NeOnc Technologies receives $2.5 million NIH grants for NEO212 development
-
New to The Street Signs NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI) to 12-Part National Broadcast Series Including T.V. Network Features, Earned Media, Commercials, and Iconic Outdoor Billboards
-
NeOnc Technologies gets board approval for $50 million Quazar deal
-
NeOnc Technologies signs $50 million term sheet for MENA expansion
-
NeOnc Technologies signs $50M term sheet with Quazar Investment for MENA expansion
-
NeOnc Technologies Holdings (NTHI) Appoints Josh Neman as Chief Clinical Officer

